Skip to main content
. 2020 Oct 19;15(10):e0240358. doi: 10.1371/journal.pone.0240358

Table 2. Basic characteristics and anthropometric values of the subjects at baseline.

Total Subjects (n = 128) Placebo Group (n = 62) Bio-Germanium Group (n = 66)
Baseline Baseline Baseline P
Male / Female n, (%) 13(10.16) / 115(89.84) 4(6.45) / 58(93.55) 9(13.64) / 57(86.36) 0.179
Age (year) 53.64 ± 11.08 53.31 ± 10.67 53.95 ± 11.53 0.742
Weight (kg) 60.87 ± 9.40 60.86 ± 10.18 60.88 ± 8.68 0.989
Height (cm) 159.20 ± 6.21 158.85 ± 6.18 159.53 ± 6.26 0.539
Leukocyte counts (×103/μL) 5.45 ± 1.04 5.52 ± 1.02 5.38 ± 1.06 0.427
Systolic BP (mmHg) 115.90 ± 12.32 115.53 ± 12.95 116.24 ± 11.78 0.746
Diastolic BP (mmHg) 70.48 ± 8.54 70.16 ± 8.96 70.77 ± 8.19 0.687
Current smoker n, (%) 3 (2.34) 0 (0.00) 3 (4.55) 0.2451
Current drinker n, (%) 43 (33.59) 18 (29.03) 25 (37.88) 0.110
Exercise +3 times per week n, (%) 64 (50.00) 29 (46.77) 35 (53.03) 0.771
Family history of immune disease n, (%) 0 (0.00) 0 (0.00) 0 (0.00) -

The data represent subject count, percentage and the mean ± standard deviation at baseline.

P-values were derived from a chi-square test (noncontinuous variables) or independent t-test (continuous variables).

1 Derived from Fisher’s exact test.

- Not applicable.